
Pluri Inc. — Investor Relations & Filings
Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Report of Periodic or Interim Report | 2026-05-14 | English | |
| Report of Periodic or Interim Report | 2026-05-14 | English | |
| QUARTERLY REPORT | 2026-05-14 | English | |
| Other Report or Announcement | 2026-04-23 | English | |
| Other Report or Announcement | 2026-04-23 | English | |
| Immediate Report of Meeting | 2026-04-23 | English |
Browse filings by year
26 years- 2026 29 filings
- 2025 186 filings
- 2024 146 filings
- 2023 89 filings
- 2022 102 filings
- 2021 106 filings
- 2020 215 filings
- 2019 136 filings
- 2018 128 filings
- 2017 210 filings
- 2016 182 filings
- 2015 184 filings
- 2014 223 filings
- 2013 172 filings
- 2012 144 filings
- 2011 147 filings
- 2010 50 filings
- 2009 57 filings
- 2008 37 filings
- 2007 35 filings
- 2006 32 filings
- 2005 34 filings
- 2004 32 filings
- 2003 38 filings
- 2002 10 filings
- 2001 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46254782 | Report of Periodic or Interim Report | 2026-05-14 | English | ||
| 46254775 | Report of Periodic or Interim Report | 2026-05-14 | English | ||
| 46258486 | QUARTERLY REPORT | 2026-05-14 | English | ||
| 35884972 | Other Report or Announcement | 2026-04-23 | English | ||
| 35884960 | Other Report or Announcement | 2026-04-23 | English | ||
| 35884954 | Immediate Report of Meeting | 2026-04-23 | English | ||
| 35884943 | Immediate Report of Meeting | 2026-04-23 | English | ||
| 35865969 | ARS - Pluri Inc. (0001158780) (Filer) | 2026-04-23 | English | ||
| 35866024 | DEF 14A - Pluri Inc. (0001158780) (Filer) | 2026-04-23 | English | ||
| 33059057 | Immediate Report | 2026-03-27 | English | ||
| 33059053 | Immediate Report | 2026-03-27 | English | ||
| 33057771 | 8-K - Pluri Inc. (0001158780) (Filer) | 2026-03-27 | English | ||
| 33048445 | Other Report or Announcement | 2026-03-26 | English | ||
| 33048441 | Other Report or Announcement | 2026-03-26 | English | ||
| 32863707 | The Company received a letter from Nasdaq, determining that the Company has regained compliance with Listing Rule | 2026-03-02 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Asymchem Laboratories (Tianjin) Co., Ltd.
Global CDMO providing integrated CMC services across the dr…
|
002821 | CN | Manufacturing |
|
ATAI Life Sciences N.V.
Develops psychedelic-inspired therapies for mental health d…
|
ATAI | NL | Manufacturing |
|
Atea Pharmaceuticals, Inc.
Clinical-stage biopharma developing oral antiviral therapie…
|
AVIR | US | Manufacturing |
|
Athira Pharma, Inc.
Biopharma firm developing small molecule therapeutics for n…
|
ATHA | US | Manufacturing |
|
Atlas Global Brands Inc.
Global cannabis company spanning cultivation, manufacturing…
|
ATL | CA | Manufacturing |
|
ATOSSA THERAPEUTICS, INC.
Clinical-stage biopharmaceutical company developing oncolog…
|
ATOS | US | Manufacturing |
|
Atrium Innovations Inc.
Develops, manufactures, and sells science-based natural hea…
|
ATB | CA | Manufacturing |
|
aTYR PHARMA INC
Develops medicines based on tRNA synthetase biology for fib…
|
ATYR | US | Manufacturing |
|
Aura Biosciences, Inc.
Develops Virus-Like Drug Conjugates as targeted therapies f…
|
AURA | US | Manufacturing |
|
Aurinia Pharmaceuticals Inc.
Biopharmaceutical company developing therapies for severe a…
|
AUPH | CA | Manufacturing |
Pluri Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/6990/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=6990 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=6990 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=6990 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 6990}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pluri Inc. (id: 6990)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.